• SCREEN EVERY ELIGIBLE PATIENT AT AVERAGE RISK FOR COLORECTAL CANCER (CRC)

    ONE YES AT A TIME

    Offering patients a choice in CRC screening matters. Cologuard is an effective, noninvasive CRC screening option for patients aged 45 years and older at average risk.1

    See why choice matters

  • The Effect of a Shared Decision-Making Process on Acceptance of
    Colorectal Cancer Screening2

    Study data as published in Annals of Family Medicine in 2022


    View the article

  • Katie Couric 

    Is on a Mission to Screen 

    Katie Couric, award-winning journalist and colorectal cancer screening advocate, is teaming up with Exact Sciences to highlight the urgent need to get patients screened for CRC.

Learn why early detection of CRC is vital

See the Cologuard clinical evidence

Order Cologuard